Our Board

PDX was set up by a team of professionals with over 120 years combined experience maximising the use of IT technology in improving the effectiveness of clinical systems and processes.

Clive Minihan

Clive Minihan

Clive Minihan has an astute business brain that has been honed over 30 years of working with start-ups and dynamic small technology companies, in both the UK and USA.  Taking some businesses from their day zero to their final successful exit, has provided the insight that PD2X requires, as it channels its expertise into high-growth areas and markets and attracts investors seeking strong returns.  Having handled exits totalling around £200 million, Clive understands how to build highly successive businesses that will produce returns on investment.

Equally passionate about the One Health philosophy as Andrew, he drives PD2X forward, engineering partnerships that can help the company capitalise on its outstanding software solutions.

Clive has an MBA from the highly respected Harvard Business School and also has an MA from Oxford University.  He is a qualified accountant and Treasurer of the Harvard Business School Club of London.  He is also a Mentor on the NHS England Clinical Entrepreneurs Programme.

Andrew Halliday

Andrew Halliday

Andrew is a co-founder of PD2X, in partnership with Clive Minihan, with whom he has enjoyed two previous hugely successful cloud-based software collaborations.

With a degree in Zoology, from the University of Leeds, and a Masters’ Degree in Biology (Manchester University), Andrew has a natural affinity with both the animal and human healthcare worlds and is passionate about the One Health philosophy.  His in-depth experience as Chief Technology Officer at various Health Tech companies over the last 15 years, also equips him with the IT skills to channel his scientific and biological knowledge into on-point, digital IT solutions.

His experience, as co-founder of Health Team Ltd (aka knowmalaria) – a company helping to safeguard travellers against the hazards of diseases not usually encountered on British shores ­– now underpin the services delivered by Pinpoint Travel Health, one of PD2X’s exciting Group brands.

Professor Stephen Smith

Professor Stephen Smith

Professor Stephen Smith – an academic and health executive who served at the University of Cambridge as Professor of Obstetrics and Gynaecology and Head of the Department of Obstetrics and Gynaecology (1988–2003),
was Principal of the Faculty of Medicine at Imperial College, London and Chief Executive of Imperial College Healthcare NHS Trust at its inception in 2007 then the largest such trust in the United Kingdom. Later on, he was Dean of the Faculty of Medicine at the University of Melbourne having been the Founding Dean of the School of
Medicine in Singapore. He was a founder of the Sino-Chinese biotechnology company, GNI Group Ltd.

Guy Cogan

Guy Cogan

Guy Cogan – a former Senior Partner of the Monitor Group, a global consulting business, he started his career at Bain and Company in London, England, ultimately serving between 1986 and 1989 as the Managing Partner of that firm’s UK operations. Guy subsequently co-founded and led a private investment firm focused on acquiring and
managing the turnaround of underperforming companies. Mr. Cogan received his MBA at the Harvard Graduate Business School, where he was named a Baker Scholar. He took his undergraduate degree in Engineering at Cambridge University in England. Guy lives in Canada.

Stephen Murphy

Stephen Murphy

Stephen Murphy – worked for the Virgin Group for many years, becoming CEO from 2005 to 2011. He has
previously been a Non-Executive Director at the Business Growth Fund. He is currently Chair of energy company Ovo and a non-executive Director of wealth management company London and Capital.